M. Dantes - Concepedia

Author

M. Dantes

Ludwig-Maximilians-Universität München ORCID

Also Known As

Dantes, Maurice, M Dantes, M. Dantes, M.C. De Souza Dantes, MAURICE DANTES, Maurice Dantes

Publications

326

Citations

H-Index

Concepts

All Affiliations

Ludwig-Maximilians-Universität München LMU Klinikum German Center for Lung Research Deutschen Konsortium für Translationale Krebsforschung Asklepios Fachkliniken München-Gauting

About

M. Dantes is an author at Ludwig-Maximilians-Universität München specializing in medicine, health sciences, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	127
2	Health Sciences	3	3	60
3	Cancer Metabolism	2	2	38
4	Cancer Therapeutics	2	2	38
5	Radiation Medicine	1	1	22

M. Dantes

Publications

179

Citations

H-Index

Page 1

	Year	Citations
RANDOMISED TRIAL OF ALTERNATIVE FORMULATIONS OF ORAL POLIOVACCINE IN BRAZIL P.A. Patriarca, G. Palmeira, J. Lima Filho, The Lancet VaccinationClinical Infectious DiseasePharmacotherapyAntimicrobial ChemotherapyInfection Control	1988	67
Performance Status and Its Changes Predict Outcome for Patients With Inoperable Stage III NSCLC Undergoing Multimodal Treatment Lukas Käsmann, Julian Taugner, Chukwuka Eze, Anticancer Research	2019	25
Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer Olarn Roengvoraphoj, Cherylina Wijaya, Chukwuka Eze, Strahlentherapie und Onkologie RadiologyMedicineCancer TreatmentOncologyRadiation Oncology	2017	24
State of clinical research of radiotherapy/chemoradiotherapy and immune checkpoint inhibitor therapy combinations in solid tumours—a German radiation oncology survey Lukas Käsmann, Chukwuka Eze, M. Dantes, European Journal of Cancer Radiation MedicineRadiation TherapyMedicineImmune Checkpoint InhibitorClinical Radiation Oncology	2019	22
Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy Julian Taugner, Lukas Käsmann, Chukwuka Eze, Translational Lung Cancer Research	2019	17
How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience Olarn Roengvoraphoj, Chukwuka Eze, Cherylina Wijaya, European Journal of Nuclear Medicine and Molecular Imaging OncologyRadiation TherapyMedicineStage Iii NsclcSingle-centre Experience	2018	14
Concurrent Afatinib and Whole-Brain Radiotherapy in Exon 19-del-EGFR Mutant Lung Adenocarcinoma: A Case Report and Mini Review of the Literature Chukwuka Eze, Nina-Sophie Schmidt-Hegemann, Olarn Roengvoraphoj, Frontiers in Oncology	2017	10

Page 1